Publication | Open Access

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

Long-term ResultsNeuro-oncologyRadiation MedicineRadiation TherapyMedicineHigh-grade GliomasLow-grade GliomasPhase 2Radiation OncologyOncologyGliomaCancer TreatmentRadiologyHealth Sciences